SS Innovations International, Inc. (NASDAQ: SSII), a developer of surgical robotic technologies, announced the appointment of Sarah M. Romano as chief financial officer, effective August 3, 2026. Romano brings over two decades of finance leadership experience in the medical technology and life sciences sectors. Based in the United States, she will help lead the company's financial operations as it advances its global expansion strategy, including pursuit of U.S. FDA approval for its SSi Mantra surgical robotic system.
Most recently, Romano served as chief financial officer of Vicarious Surgical, where she led financial and operational initiatives to reduce cash burn, strengthen the balance sheet, and support strategic objectives. She previously held CFO roles at Entero Therapeutics and Kiora Pharmaceuticals, raising more than $100 million through public and private financings while overseeing strategic transactions, SEC reporting, and investor relations. Her proven track record in financial management and capital raising will be instrumental as SS Innovations seeks to scale its operations and bring its surgical robotic technologies to new markets.
The appointment comes at a pivotal time for SS Innovations, which is focused on making the benefits of robotic surgery affordable and accessible globally. The company's product range includes its proprietary "SSi Mantra" surgical robotic system and its comprehensive suite of "SSi Mudra" surgical instruments, which support a variety of surgical robotic procedures including cardiac surgery. As an American company headquartered in India, SS Innovations plans to expand the global presence of its technologically advanced, user-friendly, and cost-effective surgical robotic solutions. The company's pursuit of FDA approval for the SSi Mantra system could significantly broaden its market reach and impact patient care worldwide.
For more details, the full press release is available at https://ibn.fm/pAqlP. Additionally, the latest news and updates relating to SSII are available in the company's newsroom at https://ibn.fm/SSII.
